Archives

img-01

Quick Asia Medical Device Regulatory Updates (February 2026)

India’s Central Drugs Standard Control Organization (CDSCO) has released the final list of risk classifications for oncology-related medical devices. The classification system, published on January 2, 2026, improves transparency concerning the regulation of cancer med-tech devices. It gives manufacturers of oncology devices... Read More

img-01

Clinical Trials in Asia Gain Momentum

Approximately 50% of global clinical trials are conducted in the Asia Pacific region today. The clinical trial landscape of Asia has been expanding beyond China in recent years. Although over 60% of the clinical trials in the region were initiated in China... Read More

img-01

India Releases Draft Guidance on Medical Device Software

For the first time, India’s Central Drugs Standard Control Organization (“CDSCO”) has issued a Draft Guidance on Medical Device Software to regulate software-based medical devices, including AI-based devices. This guidance aims to clarify the classification, licensing, validation, and post-marketing surveillance of Software... Read More

img-01

Quick Asia Regulatory Updates (October 2025)

India has released a draft bill calling for greater accountability from clinical trial sponsors and contract research organizations (CROs). Companies will need to pay damages and treat participants who suffer from injuries during any trials. If the trial sponsors do not comply, companies would face a... Read More